Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD of SYNAPTICS Inc from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
SYNAPTICS Inc quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and change rate from Q3 2018 to Q3 2025.
  • SYNAPTICS Inc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 27 Sep 2025 was $68.4M.
  • SYNAPTICS Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $101M.
  • SYNAPTICS Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was -$12.3M, a 117% decline from 2020.
  • SYNAPTICS Inc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2020 was $72.9M, a 83.3% decline from 2019.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

SYNAPTICS Inc Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $68.4M +$91.7M 29 Jun 2025 27 Sep 2025 10-Q 06 Nov 2025
Q3 2024 -$23.3M +$100M +81.1% 30 Jun 2024 28 Sep 2024 10-Q 06 Nov 2025
Q3 2023 -$123M -$167M -382% 25 Jun 2023 30 Sep 2023 10-Q 07 Nov 2024
Q3 2022 $43.8M +$533M 26 Jun 2022 24 Sep 2022 10-Q 09 Nov 2023
Q3 2021 -$489M +$94.2M +16.2% 27 Jun 2021 25 Sep 2021 10-Q 03 Nov 2022
Q3 2020 -$583M -$606M -2636% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2020
Q3 2019 $23M +$60.7M 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q3 2018 -$37.7M 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019

SYNAPTICS Inc Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $101M +$113M 26 Jun 2022 24 Jun 2023 10-K 18 Aug 2023
2021 -$12.3M -$85.2M -117% 27 Jun 2021 25 Jun 2022 10-K 18 Aug 2023
2020 $72.9M -$363M -83.3% 28 Jun 2020 26 Jun 2021 10-K 18 Aug 2023
2019 $436M +$409M +1525% 30 Jun 2019 27 Jun 2020 10-K 22 Aug 2022
2018 $26.8M 01 Jul 2018 29 Jun 2019 10-K 23 Aug 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.